63 studies were found. Here are studies 1 to 50.

1.		Recruiting	Liver Perfusion of Melphalan in Inoperable Liver Cancer Conditions: Liver Neoplasm; Neoplasm Metastasis
2.		Recruiting	Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma Conditions: Hepatocellular Carcinoma; Liver Cancer
3.		Recruiting	Chemotherapy in Treating Children With Liver Cancer Conditions: childhood hepatoblastoma; childhood hepatocellular carcinoma; childhood liver cancer
4.		Recruiting	Temozolomide and O6-Benzylguanine for Treating Childhood Cancers Conditions: Brain Neoplasm; Embryonal Neoplasm; Ewing's Sarcoma; Germ Cell Neoplasm; Liver Neoplasm; Nephroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma
5.		Recruiting	Study of NS-9 in Patients with Liver Metastases Conditions: Liver Neoplasms; Neoplasm Metastasis; Local Neoplasm Recurrences
6.		Recruiting	Study of the Litx™ System Combined with Chemotherapy in Patients With Colorectal Liver Metastases Conditions: Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis
7.		Recruiting	Vaccine Therapy and Radiation to Liver Metastasis With or Without Celecoxib in Patients with CEA-Positive Solid Tumors Condition: Liver Neoplasms
8.		Recruiting	Photodynamic therapy with talaporfin sodium (LS11) in treating patients with refractory colorectal liver metastases Conditions: Liver Metastasis; Colorectal Neoplasms; Liver Neoplasms; Neoplasm Metastasis
9.		Recruiting	Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma. Condition: Liver Neoplasms
10.		Recruiting	Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma Condition: Liver Neoplasms
11.		Recruiting	Safety and Tolerability of I.V. Infusion of MB07133 in Patients with Unresectable Hepatocellular Carcinoma Condition: Hepatocellular Carcinoma
12.		Recruiting	Prevention of Recurrent Hepatitis B after Liver Transplantation Conditions: Hepatitis B; Cirrhosis; Acute Liver Failure; Hepatocellular Carcinoma
13.		Recruiting	The Use of Radiofrequency Ablation to Treat Hepatic Neoplasms Condition: Liver Neoplasm
14.		Recruiting	A Study to Estimate Safety and Efficacy of Bay 43-9006 in the Treatment of Hepatocellular Carcinoma Condition: Carcinoma, Hepatocellular
15.		Recruiting	Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IVA Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
16.		Recruiting	Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer
17.		Recruiting	Doxorubicin and Bortezomib in Treating Patients With Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
18.		Recruiting	Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer Conditions: adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized resectable adult primary liver cancer
19.		Recruiting	Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) Conditions: advanced adult primary liver cancer; adult primary hepatocellular carcinoma
20.		Recruiting	Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
21.		Recruiting	TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) Conditions: advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
22.		Recruiting	Epirubicin and Thalidomide in Treating Patients With Liver Cancer Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
23.		Recruiting	Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer Conditions: adult primary hepatocellular carcinoma; recurrent adult primary liver cancer; localized unresectable adult primary liver cancer
24.		Recruiting	Oxaliplatin in Treating Patients With Liver Cancer Conditions: advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
25.		Recruiting	Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery Conditions: localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
26.		Recruiting	Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction Conditions: recurrent adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
27.		Recruiting	Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer
28.		Recruiting	Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
29.		Recruiting	Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
30.		Recruiting	Hepatic Arterial Infusion Plus Internal Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Conditions: localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
31.		Recruiting	Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer Conditions: localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma
32.		Recruiting	Vaccine Therapy in Treating Patients With Liver Cancer Conditions: localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
33.		Recruiting	Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
34.		Recruiting	Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; adult primary hepatocellular carcinoma
35.		Recruiting	Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
36.		Recruiting	Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction Conditions: adult non-Hodgkin's lymphoma; adult primary liver cancer; adult solid tumor
37.		Recruiting	BMS-247550 in Treating Patients With Liver or Gallbladder Cancer Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
38.		Recruiting	Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer Conditions: adult primary liver cancer; cholangiocarcinoma of the extrahepatic bile duct; cholangiocarcinoma of the gallbladder; ...
39.		Recruiting	A Trial of Thymalfasin in Adult Patients with Hepatocellular Carcinoma Condition: Carcinoma, Hepatocellular
40.		Recruiting	Study of DENSPM in Patients with Liver Cancer who are Not Eligible for Surgical Cure Condition: Carcinoma, Hepatocellular
41.		Recruiting	Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation Conditions: Liver Transplantation; Hepatitis; Cholestasis; Carcinoma, Hepatocellular
42.		Recruiting	Testing of ADI-PEG in Hepatocellular Carcinoma Condition: Carcinoma, Hepatocellular
43.		Recruiting	Stem Cell Transplantation for Metastatic Solid Tumors Conditions: Cholangiocarcinoma; Colon/Rectal Ca; Bladder Ca; Breast Ca; Basal Cell Ca; Adrenal Ca; Esophageal/Gastric Ca; Hepatocellular Ca; Ovarian Ca; ...
44.		Recruiting	Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors Conditions: advanced adult primary liver cancer; liver metastases; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer
45.		Recruiting	Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; liver metastases
46.		Recruiting	Bortezomib as First-Line Systemic Therapy in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer
47.		Not yet recruiting	Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma Conditions: childhood hepatoblastoma; stage IV childhood liver cancer
48.		Recruiting	Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer; Pain
49.		Recruiting	Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer Conditions: stage IV colon cancer; Stage IV rectal cancer; liver metastases; recurrent rectal cancer; recurrent colon cancer
50.		Not yet recruiting	Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer Conditions: liver metastases; stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer